Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle

BACKGROUND: Obesity-induced skeletal muscle inflammation is a major contributor of skeletal muscle loss/atrophy and is implicated in metabolic complications such as insulin resistance. Fibroblast growth factor 21 (FGF21) is known to be an important metabolic regulator with anti-inflammatory properti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chu-Sook, Joe, Yeonsoo, Choi, Hye-Seon, Back, Sung Hoon, Park, Jeong Woo, Chung, Hun Taeg, Roh, Eun, Kim, Min-Seon, Ha, Tae Youl, Yu, Rina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611052/
https://www.ncbi.nlm.nih.gov/pubmed/31312114
http://dx.doi.org/10.1186/s12950-019-0221-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611052/
https://www.ncbi.nlm.nih.gov/pubmed/31312114
http://dx.doi.org/10.1186/s12950-019-0221-3

Ejemplares similares